Medical Editor: John P. Cunha, DO, FACOEP
Carteolol Hydrochloride Ophthalmic Solution is a beta-blocker used to treat open-angle glaucoma and other causes of high pressure inside the eye. Carteolol hydrochloride ophthalmic is available in generic form. Common side effects of carteolol hydrochloride ophthalmic include:
- mild burning
- itching, or watering of your eyes
- blurred or cloudy vision
- mildly swollen or puffy eyes
- increased sensitivity of your eyes to light
- trouble seeing at night
- droopy eyelids
- muscle weakness
- sleep problems (insomnia)
- stuffy nose
- nausea, or
- altered sense of taste
The usual dose is one drop of carteolol hydrochloride ophthalmic solution 1% in the affected eye(s) twice a day. Carteolol hydrochloride ophthalmic may interact with oral carteolol, digoxin, reserpine, insulin or oral diabetes medications, other beta-blockers, calcium channel blockers, or medicines to treat psychiatric disorders. Tell your doctor all medications and supplements you use. During pregnancy, carteolol hydrochloride should be used only if prescribed. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is unknown if this drug passes into breast milk or if it could harm a nursing baby. Consult your doctor before breastfeeding.
Our Carteolol Hydrochloride Ophthalmic Solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using this medication and call your doctor at once if you have any of these serious side effects:
- severe swelling, itching, burning, redness, pain, or discomfort in or around your eye;
- drainage, crusting, or oozing of your eyes or eyelids;
- bronchospasm (wheezing, chest tightness, trouble breathing);
- slow heart rate, weak pulse, fainting, slow breathing (breathing may stop);
- fast or pounding heartbeats;
- feeling short of breath, even with mild exertion; or
- swelling, rapid weight gain.
Less serious side effects may include:
- mild burning, stinging, itching, or watering of your eyes;
- blurred or cloudy vision;
- mildly swollen or puffy eyes;
- increased sensitivity of your eyes to light;
- trouble seeing at night;
- droopy eyelids;
- headache, dizziness, depression ;
- muscle weakness;
- sleep problems (insomnia);
- stuffy nose; or
- nausea, altered sense of taste.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Carteolol Hydrochloride (Carteolol)
The following adverse reactions have been reported in clinical trials with Carteolol Hydrochloride (carteolol) Ophthalmic Solution.
Transient eye irritation, burning, tearing, conjunctival hyperemia and edema occurred in about 1 of 4 patients. Ocular symptoms including blurred and cloudy vision, photophobia, decreased night vision, and ptosis and ocular signs including blepharoconjunctivitis, abnormal corneal staining, and corneal sensitivity occurred occasionally.
As is characteristic of nonselective adrenergic blocking agents, Carteolol may cause bradycardia and decreased blood pressure (See WARNINGS). The following systemic events have occasionally been reported with the use of Carteolol Hydrochloride (carteolol) Ophthalmic Solution: cardiac arrhythmia, heart palpitation, dyspnea, asthenia, headache, dizziness, insomnia, sinusitis, and taste perversion. The following additional adverse reactions have been reported with ophthalmic use of beta1 and beta2 (nonselective) adrenergic receptor blocking agents:
Body As a Whole
Hypersensitivity, including localized and generalized rash
Signs and symptoms of keratitis, blepharoptosis, visual disturbances including refractive changes (due to withdrawal of miotic therapy in some cases), diplopia, ptosis. Other reactions associated with the oral use of nonselective adrenergic receptor blocking agents should be considered potential effects with ophthalmic use of these agents.
Read the entire FDA prescribing information for Carteolol Hydrochloride (Carteolol)
© Carteolol Hydrochloride Patient Information is supplied by Cerner Multum, Inc. and Carteolol Hydrochloride Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.